XM does not provide services to residents of the United States of America.

Cboe to list hedged ADRs developed by Precidian



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Cboe to list hedged ADRs developed by Precidian</title></head><body>

By Laura Matthews

NEW YORK, Oct 7 (Reuters) -Precidian Investments launched hedged ADRs on Monday that U.S. investors can use to buy foreign-listed stocks while limiting the impact offluctuating currencies.

Precidian, an exchange-traded fund developer, said itwill list the hedged American Depositary Receipts on Cboe's U.S. equities exchange.

Investors buying shares of companies overseas, including ADRs, are exposed to fluctuating exchange rates between the dollar and the foreign currency. But by coupling the ADRs with a currency overlay into one security, investors can mitigate currency exposure, said Cboe.

The Canadian Imperial Bank of Commerce will be the counterparty providing the currency hedge.

"This really is the next generation ADR for U.S. investors," Rob Marrocco, global head of ETP listings at Cboe, told Reuters. The product will be called ADRhedged.

Cboe's U.S. equities exchange will initially list AstraZeneca AZN.L ADRhedged, HSBC Holdings HSBA.L ADRhedged and Shell SHEL.L ADRhedged and anticipates adding another 14 soon after.

Stuart Thomas, founding principal at Precidian, told Reuters that the more than $1 trillion ADR market has needed a hedged alternative for decades.

ADRhedged comes as the greenback's appreciation against most global currencies over the past decade has caused ADR investments to underperform in dollar terms, said Cboe.

"People have been buying them for years, but the average investor has not had access to a currency hedge overlay for international investing," said Thomas. "Now you've got another set of tools at your disposal."



Reporting by Laura Matthews; editing by Megan Davies and Cynthia Osterman

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.